Genetic Polymorphism of

GABRG2 adverse drug reactions children with epilepsy gene polymorphism therapeutic response valproic acid

Journal

Pharmacogenomics and personalized medicine
ISSN: 1178-7066
Titre abrégé: Pharmgenomics Pers Med
Pays: New Zealand
ID NLM: 101514107

Informations de publication

Date de publication:
2021
Historique:
received: 15 07 2021
accepted: 02 09 2021
entrez: 23 9 2021
pubmed: 24 9 2021
medline: 24 9 2021
Statut: epublish

Résumé

Valproic acid (VPA) is recommended as a first-line treatment for children with epilepsy. The purpose of this study was to explore the association of A retrospective study including 96 Chinese children with epilepsy treated by VPA was carried out. The ADRs were collected during VPA therapy and Among 96 patients, 41 individuals were defined as seizure together with 49 patients with seizure-free and 6 patients unclassified. Carriers of homozygote This study revealed that

Sections du résumé

BACKGROUND BACKGROUND
Valproic acid (VPA) is recommended as a first-line treatment for children with epilepsy.
OBJECTIVE OBJECTIVE
The purpose of this study was to explore the association of
METHODS METHODS
A retrospective study including 96 Chinese children with epilepsy treated by VPA was carried out. The ADRs were collected during VPA therapy and
RESULTS RESULTS
Among 96 patients, 41 individuals were defined as seizure together with 49 patients with seizure-free and 6 patients unclassified. Carriers of homozygote
CONCLUSION CONCLUSIONS
This study revealed that

Identifiants

pubmed: 34552348
doi: 10.2147/PGPM.S329594
pii: 329594
pmc: PMC8450188
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1141-1150

Informations de copyright

© 2021 Lu et al.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Eur J Neurosci. 2005 Jul;22(1):10-20
pubmed: 16029191
Epilepsy Res. 2013 Nov;107(1-2):1-8
pubmed: 24076030
Epilepsy Curr. 2009 Jan-Feb;9(1):18-23
pubmed: 19396344
Neurol India. 2012 Nov-Dec;60(6):585-8
pubmed: 23287319
J Hum Genet. 2017 Dec;62(12):1009-1014
pubmed: 28878340
Sci Rep. 2015 Dec 17;5:18389
pubmed: 26672757
PLoS One. 2015 Dec 21;10(12):e0145538
pubmed: 26692363
Mol Neurobiol. 2017 May;54(4):2831-2842
pubmed: 27013471
Pharmacol Rev. 2020 Jul;72(3):606-638
pubmed: 32540959
Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11936-11945
pubmed: 31160440
Seizure. 2018 Aug;60:39-43
pubmed: 29894917
Behav Brain Res. 2014 Aug 15;270:316-25
pubmed: 24867334
Pharmacogenet Genomics. 2013 Nov;23(11):605-10
pubmed: 24061200
J Mol Neurosci. 2018 Jun;65(2):141-153
pubmed: 29785705
Med Glas (Zenica). 2021 Aug 01;18(2):404-409
pubmed: 34080406
Biol Res. 2016 Feb 29;49:15
pubmed: 26927389
Nat Metab. 2020 Aug;2(8):763-774
pubmed: 32719538
Prog Neurobiol. 1999 May;58(1):31-59
pubmed: 10321796
Neuropharmacology. 2003 Dec;45(7):907-17
pubmed: 14573383
Mol Neurobiol. 2016 Oct;53(8):5457-67
pubmed: 26452361
Indian J Pediatr. 2012 Nov;79(11):1514-6
pubmed: 21983990
Epilepsia. 2020 Apr;61(4):657-666
pubmed: 32141622
Neurology. 2005 Mar 8;64(5):880-2
pubmed: 15753427
Eur J Pharm Sci. 2018 Sep 15;122:170-178
pubmed: 29981400
Nat Rev Neurosci. 2004 Jul;5(7):553-64
pubmed: 15208697
Neuropharmacology. 2018 Jul 1;136(Pt A):10-22
pubmed: 29407219
Pediatr Rev. 2020 Jul;41(7):321-347
pubmed: 32611798
Dev Med Child Neurol. 2019 Jan;61(1):82-90
pubmed: 30191957
Epilepsia. 2017 Apr;58(4):512-521
pubmed: 28276062
Seizure. 2011 May;20(4):343-6
pubmed: 21236703
Clin Transl Sci. 2021 Mar 1;:
pubmed: 33650258
Science. 2017 May 26;356(6340):853-859
pubmed: 28546212
Eur J Pharm Sci. 2019 Mar 15;130:65-77
pubmed: 30684656
Sci Rep. 2020 Jul 29;10(1):12776
pubmed: 32728024
Seizure. 2010 May;19(4):237-41
pubmed: 20356767
Arch Med Sci. 2018 Jan;14(1):157-166
pubmed: 29379546
Lancet Neurol. 2016 Feb;15(2):210-218
pubmed: 26655849
Epilepsia. 2008 Apr;49(4):608-14
pubmed: 18070088
Genet Test Mol Biomarkers. 2012 Jun;16(6):550-7
pubmed: 22239287
Front Neurosci. 2020 Nov 11;14:590605
pubmed: 33262686
Curr Drug Saf. 2019;14(3):217-224
pubmed: 30854975
Cell Mol Neurobiol. 2021 Aug;41(6):1257-1269
pubmed: 32500354
Psychopharmacology (Berl). 2018 Sep;235(9):2665-2673
pubmed: 29984389
J Child Neurol. 2017 Nov;32(13):1035-1039
pubmed: 28879801

Auteurs

Jieluan Lu (J)

Department of Clinical Pharmacology, College of Pharmacy, Jinan University, Guangzhou, 510632, People's Republic of China.

Hanbing Xia (H)

Department of Pharmacy, Baoan Women's and Children's Hospital, Jinan University, Shenzhen, 518102, People's Republic of China.

Wenzhou Li (W)

Department of Pharmacy, Baoan Women's and Children's Hospital, Jinan University, Shenzhen, 518102, People's Republic of China.

Xianhuan Shen (X)

Department of Clinical Pharmacology, College of Pharmacy, Jinan University, Guangzhou, 510632, People's Republic of China.

Huijuan Guo (H)

Department of Pharmacy, Baoan Women's and Children's Hospital, Jinan University, Shenzhen, 518102, People's Republic of China.

Jianping Zhang (J)

Department of Clinical Pharmacology, College of Pharmacy, Jinan University, Guangzhou, 510632, People's Republic of China.

Xiaomei Fan (X)

Department of Pharmacy, Baoan Women's and Children's Hospital, Jinan University, Shenzhen, 518102, People's Republic of China.

Classifications MeSH